Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people taking Wegovy begin to lose weight within the first four weeks, though meaningful results (the kind you notice in how clothes fit) typically build over three to six months. In the STEP 1 trial published in the New England Journal of Medicine, adults on semaglutide 2.4mg lost an average of around 15% of their body weight over 68 weeks, with loss continuing to accumulate past the six-month mark. That trajectory matters, because Wegovy is a prescription-only medicine: a GPhC-registered prescriber assesses clinical suitability before treatment begins, and the pace of weight loss depends on a handful of factors that are genuinely worth understanding before you start.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The starting dose of Wegovy (0.25mg weekly) exists to let your body adjust to semaglutide, not to drive rapid weight loss. Nausea and digestive discomfort are most common in the first few weeks, and keeping the dose low reduces that. So if you're a fortnight in and the number on the scales hasn't shifted dramatically, that's expected. Most of the titration schedule (moving from 0.25mg through 0.5mg, 1.0mg and 1.7mg before reaching the 2.4mg maintenance dose) takes around four months to complete, with roughly four weeks at each level.
During those early months, appetite suppression gradually becomes more noticeable. Many people find that portions shrink naturally, snacking drops off, and food feels less urgent. Weight loss in this phase is typically in the range of 2–5% of starting weight. Modest, but the foundation is being laid. If you want a fuller picture of the titration timeline, our page on how long Wegovy takes to work walks through what happens at each dose step.
One thing worth knowing: how quickly you move through doses is a clinical decision, not a fixed schedule. A prescriber may slow progression if side effects are significant, and if you're wondering how long you'll need to take Wegovy to lose weight, that slower progression can shift the overall timeline in ways that are worth understanding before you start. That affects how soon you reach the dose where the most meaningful weight loss tends to happen.
The bulk of weight loss on Wegovy accumulates between the third and twelfth months of treatment. By month six, most people on the 2.4mg maintenance dose have lost somewhere between 8% and 12% of their body weight, with the average in clinical trials sitting closer to 10–12% at that point. The STEP 1 trial's 15% average at 68 weeks reflects how loss continued to build well into the second half of treatment.
This is also the point at which NICE guidance becomes relevant. Under NICE's technology appraisal TA875, if less than 5% of body weight has been lost after six months at the maintenance dose, the prescriber should review whether continuing makes sense. That's not a cliff edge, it's a prompt for a clinical conversation. The vast majority of people who tolerate the medicine and reach the maintenance dose do exceed that threshold.
Diet and activity genuinely influence the pace here. Wegovy reduces appetite; it doesn't replace protein, fibre or movement. People who make the most of reduced appetite by eating more carefully and staying active tend to see better results. The medicine creates space for better habits, what happens in that space matters. For a detailed look at how long Wegovy weight loss takes across the different phases of treatment, that page sets out what the evidence shows month by month. For context on how semaglutide compares across formulations, this page covers the broader semaglutide picture.
Wegovy is intended for long-term use, and weight loss often continues (though more slowly) beyond the first year. The STEP 1 trial ran to 68 weeks (roughly sixteen months), and participants' average weight loss was still increasing at the end of the observation period. The introduction of the higher 7.2mg dose, approved by the MHRA in early 2026, has opened up the possibility of greater loss for people who plateau on 2.4mg, with trial data reporting around 20.7% average weight loss over 72 weeks.
Under NICE's recommendation, semaglutide for weight management is approved for use within a specialist weight management context for a maximum of two years. That time limit is specific to the NHS pathway; a private prescriber follows the licensed indication and their own clinical judgement. Either way, what happens when treatment stops matters: weight tends to return without ongoing lifestyle measures in place. That's a conversation to have with your prescriber, not something to leave until the end of treatment.
People sometimes ask whether they'll need to stay on Wegovy indefinitely to keep the weight off, it's an honest question, and one our prescribers address directly at review. If you're weighing the full commitment involved, the cost and what's included section of our treatment information is a practical place to start. There's also more detail on the programme overall at our Wegovy treatment page.
Searching for how long weight loss takes on Wegovy usually means you're somewhere between curious and genuinely ready to start, and probably frustrated that a straight answer is hard to find. Here's the honest version: most people see some change within a month, meaningful loss by month three or four, and their best results between months six and twelve. Fifteen percent of body weight over around a year is the figure the trial evidence supports, with variation either side depending on dose, lifestyle and individual response.
The decision isn't really about the timeline. It's about whether supervised treatment with a licensed medicine, taken consistently, fits your situation. That's what a clinical assessment is for. A named prescriber at a GPhC-registered pharmacy reviews your answers (not an automated system) and helps you understand whether Wegovy is clinically appropriate and what realistic expectations look like for you specifically. You can explore what's involved in getting started at our treatment consultation page, or read about weight management more broadly at our weight loss overview.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.